Union Finance Minister Nirmala Sitharaman announces the Union Budget 2026–27 on 1^st February, 2026. She announced a series of measures aimed at positioning India as a global biopharma hub.

Key initiatives include the launch of the Biopharma Shakti programme with an outlay of INR 10,000 crore over next five years to strengthen research, innovation and manufacturing capabilities, including building three new National Institutes of Pharmaceutical Education and Research (NIPERs) and upgrading the seven existing ones.

She further said that Semiconductor Mission 2.0 will prioritise the development of equipment and materials built on end-to-end Indian Intellectual Property (IP)

The finance minister further announced three dedicated chemical parks along with setting up three new All India Institutes of Ayurveda (AIIAs), upgrading Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy (AYUSH) pharmacies as well as the World Health Organisation (WHO) global traditional medicine centre in Jamnagar.

The announcements underscore the government’s push to deepen industry–research linkages, enhance regulatory capacity and scale up India’s global competitiveness in pharmaceuticals and allied sectors.